---
title: "EAST-ASIA PHARMACEUTICAL: Subsidiary obtains CNAS laboratory accreditation certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/247264188.md"
description: "EAST-ASIA PHARMACEUTICAL's wholly-owned subsidiary Hangzhou Shanli Biomedical Technology Co., Ltd. has obtained the CNAS laboratory accreditation certificate, which is valid from May 20, 2025, to May 19, 2031. This accreditation enhances the laboratory's management and technical capabilities, improves the company's product quality and R&D capabilities, and promotes high-quality development, but has no significant impact on the company's current performance"
datetime: "2025-07-04T08:15:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/247264188.md)
  - [en](https://longbridge.com/en/news/247264188.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/247264188.md)
---

# EAST-ASIA PHARMACEUTICAL: Subsidiary obtains CNAS laboratory accreditation certificate

EAST-ASIA PHARMACEUTICAL announced that its wholly-owned subsidiary Hangzhou Shanli Biomedical Technology Co., Ltd. recently obtained the laboratory accreditation certificate from the China National Accreditation Service for Conformity Assessment. The certificate is effective from May 20, 2025, and will expire on May 19, 2031. This accreditation signifies that the management level and technical capabilities of the Hangzhou Shanli analysis laboratory have received national and international recognition, demonstrating the ability to conduct testing according to national standards. This will help enhance the company's product quality, research and development capabilities, and customer trust, thereby strengthening overall competitiveness and promoting high-quality development. This accreditation will not have a significant impact on the company's current performance

### Related Stocks

- [605177.CN](https://longbridge.com/en/quote/605177.CN.md)

## Related News & Research

- [Should You Be Adding Daewoong Pharmaceutical (KRX:069620) To Your Watchlist Today?](https://longbridge.com/en/news/286824214.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [While Everyone Chases AI, Pharma Keeps Getting Cheaper](https://longbridge.com/en/news/286650835.md)
- [Rare nickels that could fund your dreams](https://longbridge.com/en/news/286856785.md)
- [Claritas Rx Strengthens Executive Team with New CRO and Two VP Promotions](https://longbridge.com/en/news/286794376.md)